Home > Healthcare > Medical Devices > Diagnostic Devices > Biological Imaging Reagents Market

Biological Imaging Reagents Market Share

Report ID: GMI10770
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

Biological Imaging Reagents Market Share

The biological imaging reagents industry is characterized by the presence of several established and emerging players that offer a variety of products across the globe. The market players compete based on factors such as product quality, innovation, regulatory compliance, customer service, and pricing strategies.

Biological Imaging Reagents Market Companies

Prominent players operating in the biological imaging reagents industry include:

Bayer AG
Bracco
Carl Zeiss
Cell Signaling Technology
Danaher
General Electric Company
Guerbet
Jubilant Pharmova Limited
Luminex Corporation
Nikon Corporation
Novartis AG
Olympus Corporation
Promega Corporation
Sartorius AG
Thermo Fisher Scientific Inc

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of biological imaging reagents reached USD 12.2 billion in 2023 and is set to register 7.3% CAGR between 2024 and 2032, due to increasing prevalence of chronic conditions and substantial investments in R&D.

The clinical diagnostics segment is projected to reach USD 9.7 billion by 2032, driven by the need for enhancing the accuracy, sensitivity, and specificity of various imaging modalities.

North America market accounted for USD 4.7 billion in in 2023, led by advanced healthcare infrastructure and significant R&D investments.

Bayer AG, Bracco, Carl Zeiss, Cell Signaling Technology, Danaher, General Electric Company, Guerbet, Jubilant Pharmova Limited, Luminex Corporation, and Nikon Corporation, among others.